Literature DB >> 29436954

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer.

.   

Abstract

Entities:  

Year:  2007        PMID： 29436954      PMCID： PMC2793754          DOI： 10.1200/JOP.0768504

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  4 in total

1.  2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Authors:  R C Bast; P Ravdin; D F Hayes; S Bates; H Fritsche; J M Jessup; N Kemeny; G Y Locker; R G Mennel; M R Somerfield
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

2.  American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.

Authors:  James L Khatcheressian; Antonio C Wolff; Thomas J Smith; Eva Grunfeld; Hyman B Muss; Victor G Vogel; Francine Halberg; Mark R Somerfield; Nancy E Davidson
Journal:  J Clin Oncol       Date:  2006-10-10       Impact factor: 44.544

3.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

Review 4.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Authors:  Lyndsay Harris; Herbert Fritsche; Robert Mennel; Larry Norton; Peter Ravdin; Sheila Taube; Mark R Somerfield; Daniel F Hayes; Robert C Bast
Journal:  J Clin Oncol       Date:  2007-10-22       Impact factor: 44.544
  4 in total
  8 in total

1.  Clinicopathological and therapeutic analysis of primary breast squamous cell carcinoma.

Authors:  Zhiying Chen; Ning An; Lei Zhang; Huanliang Cui; Yuqi Jiang; Yongchun Zhang
Journal:  Gland Surg       Date:  2022-01

2.  Identification of Cell-Free Circulating MicroRNAs for the Detection of Early Breast Cancer and Molecular Subtyping.

Authors:  Karen C B Souza; Adriane F Evangelista; Letícia F Leal; Cristiano P Souza; René A Vieira; Rhafaela L Causin; A C Neuber; Daniele P Pessoa; Geraldo A S Passos; Rui M V Reis; Marcia M C Marques
Journal:  J Oncol       Date:  2019-08-08       Impact factor: 4.375

3.  Weighted Gene Co-Expression Network Analysis Identifies Hub Genes Associated with Occurrence and Prognosis of Oral Squamous Cell Carcinoma.

Authors:  You Ge; Wei Li; Qian Ni; Yan He; Jinjin Chu; Pingmin Wei
Journal:  Med Sci Monit       Date:  2019-09-28

4.  Relationships of protein biomarkers of the urokinase plasminogen activator system with expression of their cognate genes in primary breast carcinomas.

Authors:  Seth B Sereff; Michael W Daniels; James L Wittliff
Journal:  J Clin Lab Anal       Date:  2019-07-29       Impact factor: 2.352

Review 5.  The lingering mysteries of metastatic recurrence in breast cancer.

Authors:  Alessandra I Riggio; Katherine E Varley; Alana L Welm
Journal:  Br J Cancer       Date:  2020-11-26       Impact factor: 7.640

6.  Personalized Decision Making on Genomic Testing in Early Breast Cancer: Expanding the MINDACT Trial with Decision-Analytic Modeling.

Authors:  Ewout W Steyerberg; Liesbeth C de Wreede; David van Klaveren; Patrick M M Bossuyt
Journal:  Med Decis Making       Date:  2021-03-03       Impact factor: 2.583

Review 7.  Religious Denomination, Religiosity, Religious Attendance, and Cancer Prevention. A Systematic Review.

Authors:  Benedikt Kretzler; Hans-Helmut König; Linéa Brandt; Helene Rabea Weiss; André Hajek
Journal:  Risk Manag Healthc Policy       Date:  2022-01-16

8.  Identification and Validation of Circulating MicroRNA Signatures for Breast Cancer Early Detection Based on Large Scale Tissue-Derived Data.

Authors:  Xiaokang Yu; Jinsheng Liang; Jiarui Xu; Xingsong Li; Shan Xing; Huilan Li; Wanli Liu; Dongdong Liu; Jianhua Xu; Lizhen Huang; Hongli Du
Journal:  J Breast Cancer       Date:  2018-12-10       Impact factor: 3.588
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.